0000000000849992

AUTHOR

M. Fresta

showing 4 related works from this author

Bisphosphonate-polyaspartamide conjugates as bone targeted drug delivery systems.

2015

Poly-hydroxy-aspartamide was used as a backbone to synthesize bisphosphonate derivatives thus achieving macromolecular carriers to be potentially used as targeting agents for bone drug delivery. Molecules bearing bisphosphonate groups, such as aminobisphosphonate (ABP) and neridronate (NRD), have been conjugated to polyaspartamide (α,β-poly(N-2-hydroxyethyl)-dl-aspartamide, PHEA), with or without a spacer (succinic acid or 6-aminocaproic acid) thus obtaining PHEA-succinate-ABP and PHEA-caproylcarbamate-ABP and PHEA-ABP and PHEA-NRD, respectively. Bisphosphonate-polymer conjugates were physico-chemically characterized using size exclusion chromatography and 1H-NMR; and their in vitro and e…

BiodistributionMaterials scienceMedicine (all)medicine.medical_treatmentChemistry (all)Biomedical EngineeringGeneral ChemistryGeneral MedicineBisphosphonateBone tissueIn vitromedicine.anatomical_structureBiochemistryTargeted drug deliverySettore CHIM/09 - Farmaceutico Tecnologico ApplicativoIn vivoDrug deliverymedicineGeneral Materials ScienceMaterials Science (all)Ex vivoJournal of materials chemistry. B
researchProduct

Sistemi sopramolecolari cationici innovativi per la veicolazione polmonare dei bioattivi.

2010

Settore CHIM/09 - Farmaceutico Tecnologico Applicativosistemi cationici veicolazione polmonare.
researchProduct

INNOVATIVE CATIONIC SUPRAMOLECULAR VESICULAR AGGREGATES (SVAs) FOR THE PULMONARY TISSUE SELECTIVE TARGETING

2011

SVAs pulmonary tissue selective targeting
researchProduct

FOLATE RECEPTOR-TARGETED SUPRAMOLECULAR VESICULAR AGGREGATES (SVAS)FOR ANTICANCER THERAPY

2009

SUPRAMOLECULAR VESICULAR AGGREGATES
researchProduct